Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Current and Future Treatment of Hypertension in the SPRINT Era.

Phillips RA.

Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):206-13. doi: 10.14797/mdcj-11-4-206.

2.

2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertension.

Shin J, Park JB, Kim KI, Kim JH, Yang DH, Pyun WB, Kim YG, Kim GH, Chae SC; Guideline Committee of the Korean Society of Hypertension.

Clin Hypertens. 2015 Apr 8;21:2. doi: 10.1186/s40885-014-0013-2. eCollection 2015. Review.

3.

Left ventricular relative wall thickness versus left ventricular mass index in non-cardioembolic stroke patients.

Hashem MS, Kalashyan H, Choy J, Chiew SK, Shawki AH, Dawood AH, Becher H.

Medicine (Baltimore). 2015 May;94(20):e872. doi: 10.1097/MD.0000000000000872.

4.

Lifestyle factors in hypertension drug research: systematic analysis of articles in a leading cochrane report.

Wilson DE, Van Vlack T, Schievink BP, Doak EB, Shane JS, Dean E.

Int J Hypertens. 2014;2014:835716. doi: 10.1155/2014/835716. Epub 2014 Jan 28. Review.

5.

Intentional weight loss and dose reductions of antihypertensive medications: a retrospective cohort study.

Shantha GP, Kumar AA, Kahan S, Cheah SY, Cheskin LJ.

Cardiorenal Med. 2013 Apr;3(1):17-25. doi: 10.1159/000347048. Epub 2013 Feb 15.

6.

Treatment of systemic hypertension.

Aronow WS.

Am J Cardiovasc Dis. 2012;2(3):160-70. Epub 2012 Jul 25.

7.

Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach.

van Dis I, Geleijnse JM, Verschuren WM, Kromhout D.

Neth Heart J. 2012 Aug;20(7-8):320-5. doi: 10.1007/s12471-012-0268-8.

9.

Stroke, high blood pressure and the Renin-Angiotensin-aldosterone system - new developments.

Atkinson J.

Front Pharmacol. 2011 Apr 27;2:22. doi: 10.3389/fphar.2011.00022. eCollection 2011.

10.

Resistant hypertension: evaluation of the patient.

Abbott EC.

Can Fam Physician. 1983 Feb;29:291-3.

11.

Benefits from treatment and control of patients with resistant hypertension.

Doumas M, Papademetriou V, Douma S, Faselis C, Tsioufis K, Gkaliagkousi E, Petidis K, Zamboulis C.

Int J Hypertens. 2010 Dec 22;2011:318549. doi: 10.4061/2011/318549.

12.

Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death.

Hebert PR, Coffey CS, Byrne DW, Scott TA, Fagard RH, Rottman JN, Murray KT, Oates JA.

J Am Soc Hypertens. 2008 Sep-Oct;2(5):355-65.

13.

Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.

Karnes JH, Cooper-DeHoff RM.

Expert Rev Cardiovasc Ther. 2009 Jun;7(6):689-702. doi: 10.1586/erc.09.31. Review.

14.

THE RELATIONSHIP BETWEEN CIRCADIAN BLOOD PRESSURE VARIATION AND AGE ANALYSED FROM 7-DAY MONITORING.

Siegelová J, Dušek J, Fišer B, Homolka P, Vank P, Mašek M, Havelková A, Cornélissen G, Halberg F.

Scr Med (Brno). 2007 Oct 1;80(4):179-188.

15.

CHRONOBIOLOGY OF HIGH BLOOD PRESSURE.

Cornélissen G, Halberg F, Bakken EE, Wang Z, Tarquini R, Perfetto F, Laffi G, Maggioni C, Kumagai Y, Homolka P, Havelková A, Dušek J, Svačinová H, Siegelová J, Fišer B.

Scr Med (Brno). 2007 Oct;80(4):157-166.

16.

UNTREATED TRANSIENT LONGER THAN 7-DAY CHAT, CIRCADIAN HYPER-AMPLITUDE TENSION, IN A 7-YEAR PERSPECTIVE.

Schwartzkopff O, Cornélissen G, Halpin C, Katinas G, Siegelová J, Fišer B, Dušek J, Halberg F.

Scr Med (Brno). 2005;78(2):75-82.

17.

Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.

McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.

Cancer. 2008 Dec 15;113(12):3440-9. doi: 10.1002/cncr.23962.

18.

Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.

Campbell F, Dickinson HO, Cook JV, Beyer FR, Eccles M, Mason JM.

BMC Health Serv Res. 2006 Apr 5;6:47.

19.

Blood pressure as an example of a biomarker that functions as a surrogate.

Desai M, Stockbridge N, Temple R.

AAPS J. 2006 Mar 10;8(1):E146-52. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk